Career history of Paul-Henry Schmelck
Former positions of Paul-Henry Schmelck
| Companies | Position | Start | End |
|---|---|---|---|
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Director/Board Member | 2007-11-12 | 2010-03-07 |
Apicap SAS
 Apicap SAS Investment ManagersFinance Apicap SAS is a Venture Capital firm, a subsidiary of OTC Holding SAS founded in 2001. Apicap SAS is headquartered in Paris. | Private Equity Investor | - | 2009-09-30 |
PrimeBioTech
 PrimeBioTech Medical DistributorsDistribution Services PrimeBioTech develops therapeutic products based on gene therapy technologies. The private company is based in Paris, France. | President | - | 2003-12-31 |
| NANOBIOTIX | Corporate Officer/Principal | 2009-11-15 | - |
| NEOVACS | Director/Board Member | 2009-11-08 | - |
| SANOFI | Corporate Officer/Principal | - | - |
Training of Paul-Henry Schmelck
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Statistics
International
| France | 7 |
| Canada | 2 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Private Equity Investor | 1 |
Sectoral
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| SANOFI | Health Technology |
| NEOVACS | Health Technology |
| NANOBIOTIX | Health Technology |
| Private companies | 3 |
|---|---|
Apicap SAS
Apicap SAS Investment ManagersFinance Apicap SAS is a Venture Capital firm, a subsidiary of OTC Holding SAS founded in 2001. Apicap SAS is headquartered in Paris. | Finance |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
PrimeBioTech
PrimeBioTech Medical DistributorsDistribution Services PrimeBioTech develops therapeutic products based on gene therapy technologies. The private company is based in Paris, France. | Distribution Services |
- Stock Market
- Insiders
- Paul-Henry Schmelck
- Experience
